Epigenetic silencing of MicroRNA-375 regulates PDK1 expression in esophageal cancer

Digestive Diseases and Sciences

Volumn 56, Issue 10, 2011, Pages 2849-2856

  Li, Xiaoli ^a   Lin, Rui ^a   Li, Jiansheng ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Esophageal cancer; Hypermethylation; miR 375; PDK1

Indexed keywords

MICRORNA; MICRORNA 375; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; ENZYME PHOSPHORYLATION; EPIGENETICS; ESOPHAGUS CANCER; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; DNA, NEOPLASM; DOWN-REGULATION; EPIGENESIS, GENETIC; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PROTEIN-SERINE-THREONINE KINASES; UP-REGULATION;

EID: 80054774985     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1711-1     Document Type: Article

References (21)

1. M Avissar BC Christensen KT Kelsey CJ Marsit 2009 MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma Clin Cancer Res 15 2850 2855 19351747 10.1158/1078-0432.CCR-08-3131 1:CAS:528:DC%2BD1MXksV2ntrk%3D
2. M Avissar MD McClean KT Kelsey CJ Marsit 2009 MicroRNA expression in head and neck cancer associates with alcohol consumption and survival Carcinogenesis 30 2059 2063 19901002 10.1093/carcin/bgp277 1:CAS:528:DC%2BD1MXhsFGhurrO
3. A Krek D Grun MN Poy, et al. 2005 Combinatorial microRNA target predictions Nat Genet 37 495 500 15806104 10.1038/ng1536 1:CAS:528: DC%2BD2MXjsF2ksrw%3D (Pubitemid 40617277)
4. Y Ladeiro G Couchy C Balabaud, et al. 2008 MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations Hepatology 47 1955 1963 18433021 10.1002/hep.22256 1:CAS:528:DC%2BD1cXotVagtrc%3D (Pubitemid 351952843)
5. Wang WX, Wilfred BR, Madathil SK, et al. miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am J Pathol. 2010;177:334-345.
6. Liu M, Lang N, Qiu M, et al. miR-137 targets Cdc42 expression, induces cell cycle G1 arrest, and inhibits invasion in colorectal cancer cells. Int J Cancer. 2011;128:1269-1279.
7. Zhao JJ, Lin J, Lwin T, et al. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood. 2010;115:2630-2639.
8. Ding L, Xu Y, Zhang W, et al. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res. 2010;20:784-793.
9. de Souza Rocha Simonini P, Breiling A, Gupta N, et al. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res. 2010;70:9175-9184.
10. Liu AM, Poon RT, Luk JM. MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun. 2010;394:623-627.
11. EA Mathe GH Nguyen ED Bowman, et al. 2009 MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: Associations with survival Clin Cancer Res 15 6192 6200 19789312 10.1158/1078-0432.CCR-09-1467 1:CAS:528:DC%2BD1MXhtF2lurrK
12. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis. 2010;31:766-776.
13. A El Ouaamari N Baroukh GA Martens P Lebrun D Pipeleers E van Obberghen 2008 miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells Diabetes 57 2708 2717 18591395 10.2337/db07-1614 1:CAS:528:DC%2BD1MXhs1Kntro%3D
14. Tsukamoto Y, Nakada C, Noguchi T, et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res. 2010;70:2339-2349.
15. Wei L, Xu Z. Cross-signaling among phosphinositide-3 kinase, mitogen-activated protein kinase and sonic hedgehog pathways exists in esophageal cancer. Int J Cancer. Epub. 2010/09/13.
16. B Li SW Tsao YY Li X Wang MT Ling YC Wong, et al. 2009 Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway Int J Cancer 125 2576 2585 19551863 10.1002/ijc.24675 1:CAS:528:DC%2BD1MXht1WmsLbN
17. Lu Z, Cox-Hipkin MA, Windsor WT, Boyapati A. 3-phosphoinositide-dependent protein kinase-1 regulates proliferation and survival of cancer cells with an activated mitogen-activated protein kinase pathway. Mol Cancer Res. 2010;8:421-432.
18. OC Rodriguez EW Lai S Vissapragada, et al. 2009 A reduction in PTEN tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1 Am J Pathol 174 2051 2060 19443706 10.2353/ajpath.2009.080859 1:CAS:528: DC%2BD1MXmvFOqurg%3D
19. Y Liu J Wang M Wu, et al. 2009 Down-regulation of 3-phosphoinositide- dependent protein kinase-1 levels inhibits migration and experimental metastasis of human breast cancer cells Mol Cancer Res 7 944 954 19531564 10.1158/1541-7786.MCR-08-0368 1:CAS:528:DC%2BD1MXns1SktL4%3D
20. BA Ballif A Shimamura E Pae J Blenis 2001 Disruption of 3-phosphoinositide-dependent kinase 1 (PDK1) signaling by the anti-tumorigenic and anti-proliferative agent n-alpha-tosyl-l-phenylalanyl chloromethyl ketone J Biol Chem 276 12466 12475 11278584 10.1074/jbc.M009939200 1:CAS:528: DC%2BD3MXjtFyksrg%3D
21. DK Finlay LV Sinclair C Feijoo, et al. 2009 Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes J Exp Med 206 2441 2454 19808258 10.1084/jem.20090219 1:CAS:528:DC%2BD1MXhtlCltrnL